325 Results for "

HSP90

" in MedChemExpress (MCE) Product Catalog:
Products (325)

325 Results for "HSP90" in MCE Product Catalog:

259
259 Publications Verification
Cat. No.: HY-13757
CAS No.: 54965-24-1
Purity:  99.93%
Synonyms: ICI 46474; (Z)-Tamoxifen Citrate; trans-Tamoxifen Citrate
Tamoxifen Citrate (ICI 46474) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells.Tamoxifen Citrate is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen Citrate also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively. Tamoxifen Citrate activates autophagy and induces apoptosis. Tamoxifen Citrate can also be used to induce gene knockout in CreER transgenic mice .
loading...
    loading...
259
259 Publications Verification
Cat. No.: HY-13757A
CAS No.: 10540-29-1
Purity:  99.78%
Synonyms: ICI 47699; (Z)-Tamoxifen; trans-Tamoxifen
Tamoxifen (ICI 47699) is an orally active, selective estrogen receptor modulator (SERM) which blocks estrogen action in breast cells and can activate estrogen activity in other cells, such as bone, liver, and uterine cells. Tamoxifen is a potent Hsp90 activator and enhances the Hsp90 molecular chaperone ATPase activity. Tamoxifen also potent inhibits infectious EBOV Zaire and Marburg (MARV) with IC50 of 0.1 μM and 1.8 μM, respectively. Tamoxifen activates autophagy and induces apoptosis. Tamoxifen can also be dissolved in corn oil (HY-Y1888) for use in inducing gene knockout in CreER transgenic mice. Tamoxifen has better solubility in corn oil compared to Tamoxifen Citrate (HY-13757) .
loading...
    loading...
70
70 Cited Publications
Cat. No.: HY-10211
CAS No.: 75747-14-7
Purity:  99.01%
Synonyms: 17-AAG; NSC 330507; CP 127374
Tanespimycin (17-AAG) is a potent HSP90 inhibitor with an IC50 of 5 nM, having a 100-fold higher binding affinity for tumour cell derived HSP90 than normal cell derived HSP90 . Tanespimycin depletes cellular STK38/NDR1 and reduces STK38 kinase activity. Tanespimycin also downregulates the stk38 gene expression .
loading...
    loading...
46
46 Cited Publications
Cat. No.: HY-15205
CAS No.: 888216-25-9
Purity:  99.94%
Synonyms: STA-9090
Target:  

HSP Apoptosis

Research Areas:  

Cancer

Ganetespib (STA-9090) is a heat shock protein 90 (HSP90) inhibitor which exhibits potent cytotoxicity in a wide variety of hematological and solid tumor cell lines. Ganetespib has antiangiogenic effects in colorectal cancer mediated through inhibition of HIF-1α and STAT3 .
loading...
    loading...
43
43 Cited Publications
Cat. No.: HY-15230
CAS No.: 30562-34-6
Purity:  99.78%
Geldanamycin is a Hsp90 inhibitor with antimicrobial activity against many Gram-positive and some Gram-negative bacteria. Geldanamycin has anti-influenza virus H5N1 activities.
loading...
    loading...
26
26 Cited Publications
Cat. No.: HY-10215
CAS No.: 747412-49-3
Purity:  99.74%
Synonyms: VER-52296; AUY922; NVP-AUY922
Target:  

HSP Autophagy Apoptosis

Research Areas:  

Cancer

Luminespib (VER-52296) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM for HSP90α and HSP90β, respectively .
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-10389
CAS No.: 467214-20-6
Purity:  99.59%
Synonyms: 17-DMAG; KOS-1022; NSC 707545
Target:  

HSP

Research Areas:  

Cancer

Alvespimycin (17-DMAG) is a potent inhibitor of Hsp90, binding to Hsp90 with an EC50 of 62 nM.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-12024
CAS No.: 467214-21-7
Purity:  98.80%
Synonyms: 17-DMAG hydrochloride; KOS-1022 hydrochloride; BMS 826476
Target:  

HSP Apoptosis

Research Areas:  

Cancer

Alvespimycin hydrochloride (17-DMAG hydrochloride; KOS-1022; BMS 826476) is a potent inhibitor of Hsp90, binding to Hsp90 with EC50 of 62±29 nM.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-102007A
CAS No.: 1131626-47-5
Purity:  99.68%
Target:  

HSP

Research Areas:  

Cancer

Gamitrinib TPP hexafluorophosphate is a Gamitrinib (GA) mitochondrial matrix inhibitor. Gamitrinib TPP hexafluorophosphate is a mitochondrial targeted HSP90 inhibitor with anti-cancer activity.
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-13425
CAS No.: 522-17-8
Purity:  99.20%
Synonyms: (-)-Deguelin; (-)-cis-Deguelin
Deguelin, a naturally occurring rotenoid, acts as a chemopreventive agent by blocking multiple pathways like PI3K-Akt, IKK-NF-κB, and MAPK-mTOR-survivin-mediated apoptosis. Deguelin binding to Hsp90 leads to a decreased expression of numerous oncogenic proteins, including MEK1/2, Akt, HIF1α, COX-2, and NF-κB.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-11038D
Purity:  97.39%
Synonyms: PU-H71 formic
Target:  

HSP

Research Areas:  

Cancer

Zelavespib formic (PU-H71 formic) is a potent Hsp90 inhibitor with an IC50 value of 51 nM for Hsp90 in MDA-MB-468 cells .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-11038
CAS No.: 873436-91-0
Purity:  99.93%
Synonyms: PU-H71
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-11038B
CAS No.: 2095432-24-7
Purity:  98.89%
Synonyms: PU-H71 hydrochloride
Target:  

HSP

Research Areas:  

Cancer

Zelavespib (PU-H71) hydrochloride is a potent Hsp90 inhibitor, with an IC50 of 51 nM in MDA-MB-468 cells.
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-B0425A
CAS No.: 1476-53-5
Synonyms: Albamycin sodium; Cathomycin sodium
Novobiocin (Albamycin) sodium is a potent and orally active antibiotic. Novobiocin sodium also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin sodium has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin sodium shows anti-orthopoxvirus activity .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-B0425
CAS No.: 303-81-1
Synonyms: Albamycin; Cathomycin
Novobiocin (Albamycin) is a potent and orally active antibiotic. Novobiocin also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin shows anti-orthopoxvirus activity .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-14463
CAS No.: 912999-49-6
Purity:  99.92%
Synonyms: AT13387
Target:  

HSP

Research Areas:  

Cancer

Onalespib (AT13387) is a potent and cross the blood-brain barrier heat-shock-protein-90 (Hsp90) inhibitor. Onalespib inhibits the proliferation, survival and migration. Onalespib decreases the expression of EGFR, p-EGFR, AKT, P-AKT, ERK1/2, P-ERK1/2, S6, P-S6 protein. Onalespib shows antitumor activity. Onalespib has the potential for the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10389A
Synonyms: 17-DMAG TFA; KOS-1022 TFA; NSC 707545 TFA
Target:  

HSP

Research Areas:  

Cancer

Alvespimycin (17-DMAG) TFA is a potent inhibitor of Hsp90, binding to Hsp90 with an EC50 of 62 nM .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-15785
CAS No.: 1260533-36-5
Purity:  98.79%
Synonyms: TAS-116
Target:  

HSP

Research Areas:  

Cancer

Pimitespib (TAS-116) is an oral bioavailable, ATP-competitive, highly specific HSP90α/HSP90β inhibitor (Kis of 34.7 nM and 21.3 nM, respectively) without inhibiting other HSP90 family proteins such as GRP94 . Pimitespib demonstrates less ocular toxicity .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-138280
CAS No.: 897326-30-6
Purity:  99.82%
Target:  

HSP

Research Areas:  

Cancer

DTHIB is a direct and selective heat shock factor 1 (HSF1) inhibitor with a Kd of 160 nM for DTHIB binding to the HSF1 DNA binding domain (DBD). DTHIB inhibits HSF1 cancer gene signature (HSF1 CaSig) and selectively stimulates degradation of nuclear HSF1. DTHIB has potently anticancer activities and can be used for prostate cancer research .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-13469
CAS No.: 1061318-81-7
Purity:  99.82%
Synonyms: CUDC-305
Target:  

HSP

Research Areas:  

Cancer

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC50s of 100 and 103 nM for HSP90α and HSP90β, respectively .
loading...
    loading...